
FDA turns down Lilly’s eczema drug lebrikizumab
Problems at a contract manufacturing organisation have scuppered Eli Lilly’s hopes of a timely FDA approval for lebrikizumab, its IL-13 inhibitor for the treatment of atop

WHO clears Oxford malaria jab for immunisation programmes
The World Health Organisation has recommended the use of a malaria vaccine developed at Oxford University in the UK, after concluding it is 75% effective at protecting chi

mRNA scientists share Nobel prize for medicine
Katalin Karikó and Drew Weissman of the University of Pennsylvania have jointly won the 2023 Nobel Prize in Physiology or Medicine for discoveries that enabled the develop

Novartis adds another string to iptacopan’s bow
Novartis has another phase 3 trial win in its quiver for targeted factor B inhibitor iptacopan, building the case for the drug as a new oral therapy for diseases caused by

Aviva backs £1bn cancer hub in London
A £1 billion development aimed at creating a major centre for cancer research and treatment in South London has taken a step forwards with the selection of preferred bidde
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content

CRISPR-Based Therapy Analytical Development Summit
CRISPR-based therapies are undergoing a remarkable evolution, with drug developers striving to enhance the safety, precision and efficacy of their products.

4th Annual CRISPR 2.0 2023
CRISPR represents the next frontier in the cell and gene therapy landscape.

5th Annual Gene Therapy Analytical Development Summit 2023
Behind regulatory milestones like the recent accelerated FDA approval for Duchenne Muscular Dystrophy, robust and detailed analytics are the cornerstone of gene therapy development.

2nd Molecular Glue Drug Development Summit 2024
Molecular glue development continues to gain exponential momentum, with advances in screening tools, identification assays and structure-based design.

mRNA Assay Development Summit 2023
The mRNA Assay Development Summit is the first and only meeting to address the specific technical challenges of analytical, bioanalytical and potency assay development.